Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 5, 2014, Pages 508-517

  Limketkai, B N ^a,b   Bayless, T M ^a   Brant, S R ^a,b   Hutfless, S M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ULTRAVIOLET RAYS;

EID: 84905866431     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12845     Document Type: Article

References (47)

1. Abraham C, Cho JH,. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-78.
2. Tsoukas CD, Provvedini DM, Manolagas SC,. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984; 224: 1438-40.
3. Piemonti L, Monti P, Sironi M, et al,. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164: 4443-51.
4. Penna G, Adorini L,. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405-11.
5. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L,. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002; 51: 1367-74.
6. Shivananda S, Lennard-Jones J, Logan R, et al,. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-7.
7. Nerich V, Monnet E, Etienne A, et al,. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 2006; 12: 218-26.
8. Armitage EL, Aldhous MC, Anderson N, et al,. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004; 127: 1051-7.
9. Nerich V, Jantchou P, Boutron-Ruault MC, et al,. Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther 2011; 33: 940-5.
10. Khalili H, Huang ES, Ananthakrishnan AN, et al,. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012; 61: 1686-92.
11. Ananthakrishnan AN, Khalili H, Higuchi LM, et al,. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142: 482-9.
12. Froicu M, Cantorna MT,. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007; 8: 5.
13. Kong J, Zhang Z, Musch MW, et al,. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294: G208-16.
14. Cantorna MT, Munsick C, Bemiss C, Mahon BD,. 1,25- Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 130: 2648-52.
15. Laverny G, Penna G, Vetrano S, et al,. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett 2010; 131: 49-58.
16. Blanck S, Aberra F,. Vitamin D deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci 2013; 58: 1698-702.
17. Ulitsky A, Ananthakrishnan AN, Naik A, et al,. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. J Parenter Enteral Nutr 2011; 35: 308-16.
18. Bours PH, Wielders JP, Vermeijden JR, van de Wiel A,. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int 2011; 22: 2857-67.
19. Kimlin MG, Lucas RM, Harrison SL, et al,. The contributions of solar ultraviolet radiation exposure and other determinants to serum 25-hydroxyvitamin D concentrations in Australian adults: the AusD Study. Am J Epidemiol 2014; 179: 864-74.
20. Frederick JE, Lubin D,. Possible long-term changes in biologically active ultraviolet radiation reaching the ground. Photochem Photobiol 1988; 47: 571-8.
21. Long CS, Miller AJ, Lee HT, Wild JD, Przywarty RC, Hufford D,. Ultraviolet index forecasts issued by the National Weather Service. Bull Am Meteorol Soc 1996; 77: 729-48.
22. Gies P, Roy C, Javorniczky J, Henderson S, Lemus-Deschamps L, Driscoll C,. Global Solar UV Index: Australian measurements, forecasts and comparison with the UK. Photochem Photobiol 2004; 79: 32-9.
23. Wier LM, Pfuntner A, Maeda J, et al,. HCUP Facts and Figures: Statistics on Hospital-based Care in the United States, 2009. Rockville, MD: AHRQ (Agency for Healthcare Research and Quality), 2011.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
25. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9.
26. Nguyen GC, Steinhart AH,. Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality. Inflamm Bowel Dis 2008; 14: 1688-94.
27. Houchens R, Elixhauser A,. Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001.2005. #2003-2.
28. Sonnenberg A, Genta RM,. Geographic distributions of microscopic colitis and inflammatory bowel disease in the United States. Inflamm Bowel Dis 2012; 18: 2288-93.
29. Sadeghi K, Wessner B, Laggner U, et al,. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-70.
30. Palmer MT, Lee YK, Maynard CL, et al,. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 2011; 286: 997-1004.
31. Mahon BD, Wittke A, Weaver V, Cantorna MT,. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003; 89: 922-32.
32. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM,. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324: 23-33.
33. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT,. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 2386-92.
34. Froicu M, Zhu Y, Cantorna MT,. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 2006; 117: 310-8.
35. Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT,. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci U S A 2008; 105: 20834-9.
36. Simmons JD, Mullighan C, Welsh KI, Jewell DP,. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47: 211-4.
37. Pei FH, Wang YJ, Gao SL, et al,. Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese. J Dig Dis 2011; 12: 90-8.
38. Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH,. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet Test 2004; 8: 417-20.
39. Naderi N, Farnood A, Habibi M, et al,. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2008; 23: 1816-22.
40. Jostins L, Ripke S, Weersma RK, et al,. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-24.
41. Eide MJ, Weinstock MA,. Association of UV index, latitude, and melanoma incidence in nonwhite populations-US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 2005; 141: 477-81.
42. Hu S, Ma F, Collado-Mesa F, Kirsner RS,. UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 2004; 140: 819-24.
43. Hiller R, Giacometti L, Yuen K,. Sunlight and cataract: an epidemiologic investigation. Am J Epidemiol 1977; 105: 450-9.
44. Beretich BD, Beretich TM,. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler 2009; 15: 891-8.
45. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A,. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-8.
46. Kimlin MG, Olds WJ, Moore MR,. Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J Photochem Photobiol B 2007; 86: 234-9.
47. Thirumurthi S, Chowdhury R, Richardson P, Abraham NS,. Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci 2010; 55: 2592-8.